Zepp Health Regains NYSE Compliance After Meeting Minimum Share Price Requirement
Zepp Health Regains NYSE Compliance After Meeting Minimum Share Price Requirement
Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated October 2, 2024 (the "October Letter"), notifying the Company that it has regained compliance with the NYSE's continued listing criterion of a minimum share price as set forth in Section 802.01C of the NYSE Listed Company Manual (the "NYSE Minimum Price Continued Listing Criterion").
華米科技股份有限公司（"華米科技"或"公司"）（紐交所:ZEPP）是全球智能穿戴和健康科技領域的領導者，今天宣佈收到了紐約證券交易所（"紐交所"）於2024年10月2日發出的一封信（"十月信函"），通知公司已恢復符合紐交所繼續上市標準中規定的最低股價，如紐約證券交易所上市公司手冊第802.01C節所規定的（"紐交所最低價格連續上市標準"）。
As previously announced, the Company received a letter from the NYSE dated April 30, 2024, notifying the Company that it was below compliance standards due to the average closing price of the Company's American depositary shares being less than $1.00 for a consecutive 30 trading-day period. Following the receipt of the October Letter, the Company is no longer considered below the NYSE Minimum Price Continued Listing Criterion and has regained compliance regarding this matter.
正如先前宣佈的，該公司收到了紐約證券交易所於2024年4月30日發出的一封信，通知公司由於公司美國存托股的平均收盤價連續30個交易日低於1.00美元，未達到合規標準。在收到十月信函後，公司不再被視爲低於紐交所最低價格連續上市標準，已在此事項上恢復合規。
譯文內容由第三人軟體翻譯。
